Elsevier Science and Technology, June 2008, Pages: 560
- Evolution and emergence of arboviruses
- Parvovirus variation and evolution: impact on disease emergence
- Genome diversity and evolution of human papillomaviruses
- Poxvirus diversity and evolution
John Wiley and Sons Ltd, Dec 2008, Pages: 304
The Centers for Disease Control (CDC) has recognized genomics as a priority area in public health education. To help public health students and professionals achieve proficiency in the language
Elsevier Science and Technology, Dec 2010, Pages: 772
diseases - Michel Tibayrenc
(1) Molecular epidemiology and species definition of pathogens - Michel Tibayrenc
(2) Virus species- Marc Van Regenmortel
(3) Viral evolution- Hiroshi Haeno and Yoh
(4
CBR Pharma Insights, Oct 2010
)
- The evolution of online opinions
- Opinion distribution of website genres – where to focus your attention
The Consumer Perception Around Costs For Medication
- A difficult economy & high health care costs
IDATE, July 2009, Pages: 70
now set for eHealth?
1.2. The eHealth market analysis
1.3. The telecom industry perspective
2. INTRODUCTION TO eHEALTH MARKET
2.1. Challenges
2.1.1. Increasing Chronic diseases
2.1.2. Increasing
Decision Resources, Inc., Dec 2007, Pages: 22
measure?
Scope
- Disease management overview: definition and evolution of disease management and related strategies.
- Employers’ views on disease management: findings from an employer health benefit
Jain PharmaBiotech, Feb 2012, Pages: 348
pigs for transplants
Risks of xenotransplantation
World Health Organization and xenotransplantation
Ethical aspects of animal biotechnology
3. A Biotechnology Perspective of Animals Diseases
Axis Research Mind, Feb 2011, Pages: 630
Global Market Watch: The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution
John Wiley and Sons Ltd, Oct 2011, Pages: 140
, and the recognition of the importance of evolution in human and veterinary medicine and public health.
Also discussed are the rapid advances in technological methodologies that can provide important detailed molecular
Axis Research Mind, Feb 2011, Pages: 410
Global Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution
Business Insights, Jan 2011, Pages: 79
Cardiovascular disease prevalence
Sales of healthy food and drinks
Natural food and drinks
Diet food and drinks
Probiotics
Heart health
Chapter 3 Global NPD dynamics
Summary
Introduction
Decline in number of new
Business Insights, Oct 2011, Pages: 112
: China’s urban and rural population (m), 2000–50
Table: Composition of the expenditure for public health in China, 2001–08
Table: Evolution of social medical insurance in China
Table: Overview of China
Decision Resources, Inc., March 2007, Pages: 19
such as specialized disease management?
- Health plans are increasingly moving physician-administered specialty drugs from the medical benefit to the pharmacy benefit. How will this move improve health plans’ ability
Business Insights, Feb 2008, Pages: 59
growth in heart health food and drinks. Cardiovascular disease prevalence rates in the developed world are high, ranging from 8% in Japan to 12% in Germany.
-Global sales for heart health food and drinks
Axis Research Mind, Feb 2011, Pages: 653
Global Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution
Infiniti Research Limited, Sep 2011, Pages: 28
., Avedon Health Systems LLC, Thomson Reuters, and Hewlett-Packard Development Co. L.P.
Technavio’s Global Disease Management Solutions Market 2010–2014 report has been prepared based on an in-depth
Euromonitor International, Feb 2011, Pages: 52
in marketing strategies based on food product claims from disease reduction to nutrition or no claims, and also highlighting where the new opportunities linked to EFSA's approved health claims lie.
The Impact
Decision Resources, Inc., March 2008, Pages: 70
of Leading Biologics, Small-Molecule Drugs, and Pharmaceuticals
Overall in the Major Markets as a Percentage of U.S. Prices, 2006
2. Evolution of Average Drug Prices in the Statutory Health Insurance
Decision Resources, Inc., March 2009, Pages: 35
, the United States relies on the private sector for most of its healthcare provision. What are the main sources of health benefi ts? How have managed care organizations evolved? What are the patterns of health
